- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 35/39 - PancréasÎlots de Langerhans
Détention brevets de la classe A61K 35/39
Brevets de cette classe: 858
Historique des publications depuis 10 ans
|
68
|
71
|
69
|
79
|
68
|
65
|
73
|
68
|
67
|
39
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| ViaCyte, Inc. | 179 |
37 |
| Vertex Pharmaceuticals Incorporated | 1608 |
35 |
| Children's Medical Center Corporation | 1876 |
28 |
| Janssen Biotech, Inc. | 1550 |
21 |
| President and Fellows of Harvard College | 5993 |
20 |
| The Regents of the University of California | 20015 |
19 |
| Sana Biotechnology, Inc. | 155 |
17 |
| Massachusetts Institute of Technology | 10080 |
15 |
| CRISPR Therapeutics AG | 367 |
15 |
| City of Hope | 996 |
14 |
| Cornell University | 3319 |
11 |
| RegenLab USA LLC | 77 |
11 |
| Regents of the University of Minnesota | 2692 |
10 |
| Seraxis, Inc. | 18 |
10 |
| Wake Forest University Health Sciences | 723 |
10 |
| Yeda Research and Development Co. Ltd. | 1339 |
10 |
| Accelerated Biosciences Corp. | 39 |
9 |
| The Salk Institute for Biological Studies | 445 |
9 |
| University of Louisville Research Foundation, Inc. | 722 |
9 |
| Orgenesis Ltd. | 12 |
8 |
| Autres propriétaires | 540 |